Eccrine squamous syringometaplasia associated with Natalizumab

Dermatol Ther. 2022 Jul;35(7):e15576. doi: 10.1111/dth.15576. Epub 2022 May 18.

Authors

Mariana Claudia Matei¹, Alba Navarro-Bielsa¹, Tamara Gracia-Cazaña¹, Isabel Abadías-Granado², Maria Carmen Gómez-Mateo³, Yolanda Gilaberte¹

Affiliations

¹ Dermatology Service. Hospital Miguel Servet, IIS Aragon. Zaragoza University, Zaragoza, Spain.
² Department of Dermatology, Hospital de Barbastro, Huesca, Spain.
³ Pathological anatomy Service, Hospital Miguel Servet, Zaragoza, Spain.

PMID: 35581953
DOI: 10.1111/dth.15576

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Squamous Cell*
Eccrine Glands
Humans
Metaplasia
Natalizumab
Sweat Gland Neoplasms*

Substances

Natalizumab